469 related articles for article (PubMed ID: 22981672)
21. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art].
Kausch von Schmeling I
Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576
[TBL] [Abstract][Full Text] [Related]
23. [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].
Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M;
Actas Urol Esp; 2012; 36(7):389-402. PubMed ID: 22386115
[TBL] [Abstract][Full Text] [Related]
24. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
25. [Treatment and follow-up of superficial bladder cancer].
Raitanen M
Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
[No Abstract] [Full Text] [Related]
26. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
Liedberg F; Hagberg O; Holmäng S; Hosseini Aliabad A; Jancke G; Ljungberg B; Malmström PU; Åberg H; Jahnson S
Scand J Urol; 2015; 49(4):290-5. PubMed ID: 25624049
[TBL] [Abstract][Full Text] [Related]
27. Micropapillary urothelial carcinoma: clinico-pathologic review.
Perepletchikov AM; Parwani AV
Pathol Res Pract; 2009; 205(12):807-10. PubMed ID: 19767154
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
[TBL] [Abstract][Full Text] [Related]
29. Controversies in the management of T1 urothelial bladder cancer.
Azzouz H; Cauberg EC; De Reijke TM
Minerva Urol Nefrol; 2011 Dec; 63(4):309-15. PubMed ID: 21996986
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
31. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.
Onozawa M; Miyanaga N; Hinotsu S; Miyazaki J; Oikawa T; Kimura T; Takaoka E; Kawai K; Shimazui T; Sakurai H; Nishiyama H; Akaza H
Jpn J Clin Oncol; 2012 Sep; 42(9):825-30. PubMed ID: 22782963
[TBL] [Abstract][Full Text] [Related]
33. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
34. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
35. [New concepts in management of NMIBC in 2010].
Pignot G; Irani J; Bastide C; Ravery V
Prog Urol; 2011 Mar; 21 Suppl 2():S34-7. PubMed ID: 21397825
[TBL] [Abstract][Full Text] [Related]
36. ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
Kamat AM; Hegarty PK; Gee JR; Clark PE; Svatek RS; Hegarty N; Shariat SF; Xylinas E; Schmitz-Dräger BJ; Lotan Y; Jenkins LC; Droller M; van Rhijn BW; Karakiewicz PI;
Eur Urol; 2013 Jan; 63(1):4-15. PubMed ID: 23083902
[TBL] [Abstract][Full Text] [Related]
37. Current management of non-muscle-invasive bladder cancer.
Rodriguez Faba O; Gaya JM; López JM; Capell M; De Gracia-Nieto AE; Gómez Correa E; Breda A; Palou J
Minerva Med; 2013 Jun; 104(3):273-86. PubMed ID: 23748281
[TBL] [Abstract][Full Text] [Related]
38. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
[TBL] [Abstract][Full Text] [Related]
40. In search of the perfect crystal ball for Ta urothelial cancer.
Chin JL
Eur Urol; 2010 Jan; 57(1):21-2; discussion 23-4. PubMed ID: 19748172
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]